Role(s) of Microglia in Alzheimer's Disease
Role(s) of Microglia in Alzheimer's Disease
批准号:
6787715
负责人:
SAMUEL CHARLES SILVERSTEIN
金额:
$31.39万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2006-08-31
中文摘要
小胶质细胞在阿尔茨海默病中的作用尚不清楚。的相互作用
英文摘要
The role(s) of microglia in Alzheimer's disease remain unresolved. interactions of
microglia with fibrillar beta amyloid peptides (fAbeta1-42) in vitro stimulates
these cells to secrete H2O2, and pro-inflammatory cytokines. Anti-inflammatory
drugs appear to exert an ameliorating effect on AD progression, and microgloial
secretory products have been shown to be toxic to neurons. These observations
suggest that microglia promote nerve damage and speed the progress of AD.
Conversely, proteoglycans, block interactions of microglia with fAbeta in vitro,
and coat fAbeta in vivo, thereby inhibiting microglial secretion of pro-
inflammatory and neurotoxic substances, and suggesting that microglial-fAbeta
interactions are relatively innocuous. Finally, treatment of transgenic mice
expressing human amyloid precursor protein (Tg hAPP+/-) with anti-fAP IgG
enables microglia to clear fAbeta-containing senile plaque-like structures from the
brain, suggesting that microglia have the capacity to prevent and/or block
progression of AD-like pathology. In preliminary experiments we have shown that
microglial expression of surface receptors that mediate interactions with fAbeta is
developmentally regulated, that scavenger receptors AI/II on adult microglia, and
BI on astrocytes, bind fAP, that CD36 signals H2O2 secretion when microglia
adhere to fAbeta-containing matrices, and that CD18 null microglia are incapable
of secreting H2O2 when plated on these matrices. Using insights gained from these
experiments, and Fcgamma receptor I/II/III-/- and CD18 null mice expressing Tg
hAPP+/-, we will explore the roles of microglial in AD . The studies proposed have
five specific aims: #1. Characterize differences in phenotype and gene expression
patterns of newborn and adult mouse microglia treated with various growth factors,
cytokines, and fAbeta-containing matrices. #2. Determine the roles) of p2-integrins
in secretion and migration of mouse microglia and human macrophages on fAbeta-
containing murices. #3. Determine the roles) of mouse microglial Fcgamma and
complement receptors in uptake and degradation of fAbeta in vitro. #4. Assess
effects of fAbeta-containing matrices, and of products secreted by wild type, CD18
null and Fcgamma receptor null microglia on neurons. #5. Determine the effects of
fAbeta immunization of CD18 null -/Tg hAPP+/- and Fcgamma receptor null/Tg
hAPP+/- mice on AD-like pathology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Mononuclear Leukocytes in Immunity
-
批准号:7846622
-
项目类别:
-
资助金额:$6.65万
-
财政年份:2009
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
Summer Immunology Research Program for High School Science Teachers
-
批准号:7560268
-
项目类别:
-
资助金额:$10.57万
-
财政年份:2008
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
Summer Immunology Research Program for High School Science Teachers
-
批准号:8065692
-
项目类别:
-
资助金额:$5.96万
-
财政年份:2008
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
Summer Immunology Research Program for High School Science Teachers
-
批准号:8135497
-
项目类别:
-
资助金额:$11.98万
-
财政年份:2008
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
Summer Immunology Research Program for High School Science Teachers
-
批准号:7940833
-
项目类别:
-
资助金额:$12.14万
-
财政年份:2008
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
Health Sciences Research: Educating the Public - PHASE II
-
批准号:7286111
-
项目类别:
-
资助金额:$24.94万
-
财政年份:2003
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
Health Sciences Research: Educating the Public - PHASE II
-
批准号:7175645
-
项目类别:
-
资助金额:$26.38万
-
财政年份:2003
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
HEALTH SCIENCES RESEARCH: EDUCATION THE PUBLIC - PHASE I
-
批准号:6936685
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2003
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
HEALTH SCIENCES RESEARCH: EDUCATION THE PUBLIC - PHASE I
-
批准号:6803532
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2003
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
HEALTH SCIENCES RESEARCH: EDUCATION THE PUBLIC - PHASE I
-
批准号:6671545
-
项目类别:
-
资助金额:$24.3万
-
财政年份:2003
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
Role(s) of Microglia in Alzheimer's Disease
-
批准号:6649693
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2001
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
Role(s) of Microglia in Alzheimer's Disease
-
批准号:6367734
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2001
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
Role(s) of Microglia in Alzheimer's Disease
-
批准号:6533934
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2001
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
ARYL BRANCHED CHAIN ACYL COA ESTERS INHIBIT MYCOBACTERIU
-
批准号:6147623
-
项目类别:
-
资助金额:$35.82万
-
财政年份:2000
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
ARYL BRANCHED CHAIN ACYL COA ESTERS INHIBIT MYCOBACTERIU
-
批准号:6374528
-
项目类别:
-
资助金额:$37.9万
-
财政年份:2000
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
ARYL BRANCHED CHAIN ACYL COA ESTERS INHIBIT MYCOBACTERIU
-
批准号:6611027
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2000
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
ARYL BRANCHED CHAIN ACYL COA ESTERS INHIBIT MYCOBACTERIU
-
批准号:6511299
-
项目类别:
-
资助金额:$34.3万
-
财政年份:2000
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
CONFERENCE ON MICROPHAGE BIOLOGY
-
批准号:2803211
-
项目类别:
-
资助金额:$0.6万
-
财政年份:1999
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
CONFERENCE ON ENDOTHELIUM
-
批准号:2727143
-
项目类别:
-
资助金额:$0.58万
-
财政年份:1998
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
IMMUNOLOGICAL DISEASE MECHANISMS
-
批准号:2886247
-
项目类别:
-
资助金额:$20.87万
-
财政年份:1997
-
负责人:SAMUEL CHARLES SILVERSTEIN
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: